SCHEMBL7877005

SCHEMBL7877005

C[C@@H]([C@@H](CCCc1cccs1)C(=O)O)N(O)C=O

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.41
POLB P06746 3/20 0.41
SLC1A3 P43003 1/20 0.40
SLC1A2 P43004 1/20 0.40
SLC1A1 P43005 1/20 0.40
ALDH1A1 P00352 3/20 0.39
ADAM17 P78536 3/20 0.38
NPC1 O15118 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
HTT P42858 1/20 0.37
MC4R P32245 1/20 0.36
MC5R P33032 1/20 0.36
MC3R P41968 1/20 0.36
PKM P14618 1/20 0.36
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7876864 0.86 CYP2C19 (0.40) CYP2C19POLBSLC1A3SLC1A2SLC1A1
SCHEMBL7879161 0.81 GRIK1 (0.43) CYP2C19HTTPKMSMN1; SMN2
SCHEMBL4290877 0.81 GRIK1 (0.43) CYP2C19HTTPKMSMN1; SMN2
SCHEMBL7873373 0.77 LTB4R (0.44) CYP2C19ALDH1A1
SCHEMBL7953565 0.77 FDFT1 (0.43)
SCHEMBL7946312 0.76 DPP4 (0.38) TDP1L3MBTL1
SCHEMBL28899116 0.76 CYP2C19 (0.53) CYP2C19POLBSLC1A3SLC1A2SLC1A1
SCHEMBL7874743 0.76 CYP2C19 (0.48) CYP2C19POLBSLC1A3SLC1A2SLC1A1
SCHEMBL7484097 0.75 ALDH1A1 (0.37) POLBALDH1A1ADAM17NPC1HTT
SCHEMBL7431816 0.75 PPARA (0.47) ALDH1A1HTTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329400-B1 INHIBITION OR ANTAGONISM OF MATRIX METALLOPROTEASES, AND/OR TUMOR NECROSIS FACTOR-ALPHA; EXTRACELLULAR MATRIX DEGRADATION, INHIBITION OF SHEDDING OF CELL SURFACE PROTEIN ECTODOMAINS AND CD23 PROTEOLYSIS GLAXO WELLCOME INC. 2001-12-11 US claimed
US-6172064-B1 METALLOPROTEASE INHIBITOR; ANTIARTHRITIC AGENTS, ANTIDIABETIC AGENTS; ANTITUMOR AGENTS GLAXO WELLCOME INC. 2001-01-09 US claimed
US-6172064-B1 METALLOPROTEASE INHIBITOR; ANTIARTHRITIC AGENTS, ANTIDIABETIC AGENTS; ANTITUMOR AGENTS GLAXO WELLCOME INC. 2001-01-09 US disclosed